Letter to the Centers for Medicare and Medicaid Services (CMS) from PhRMA, AdvaMed, and BIO

Letter to CMS - Sunshine Act

PhRMA November 18, 2014

SHARE THIS

As life science trade associations representing thousands of medical device, biotechnology and pharmaceutical companies, we express our longstanding support for the goals of the Physician Payments Sunshine Act (“the Sunshine Act”), section 6002 of the Affordable Care Act of 2010, which will provide transparency in industry collaboration with teaching hospitals, physicians; and report physician ownership and investment interests.

StayConnected

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review "1. Information Collection."